FDA Investigator Richard W Thornton

Richard W Thornton has conducted inspections on 23 sites in 4 countries as of 21 Feb 2002. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
23
Last Inspection Date:
21 Feb 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Germany, United States of America, United Kingdom of Great Britain and Northern Ireland, Italy
FDA Investigators that have inspected at least one site in common with Richard W Thornton:
Abby Lmozeke Baker, Aimee Cunningham, PhD, Alan M Roberts, Alberto A Viciedo, Alicia Gilbert, Amber D Brodas, Amy Devlin, PhD, Anastasia M Shields, Andrew C Chang, Angela Jourdain, Anissa M Cheung, Anita R Michael, Ann Marie Montemurro, Ann Marie Schofield, Antonina Aydanian, Arie C Menachem, Aurora Miha Trifanov, Azza Talaat, Bei Y He, Brenda P King, Brentley S Collins, Brooke K Higgins, Burnell M Henry, Carl Lee, Carla Lankford, MD, PhD, Caroline H Le, Catherine J Laufmann, CDR Donald Ertel, Charles Jewell, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christopher B May, Christopher Downey, PhD, Christopher R Czajka, Concepcion Cruz, Jr, Craig D Zagata, Cynthia Jim, CSO, Cynthia L Kelley, Daniel J Grabicki, Daniel Lagasse, David Frucht, MD, David M Beltran, David P Vanhouten, Dawn M Braswell, Deborah M Trout, Demitria J Argiropoulos, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Destry M Sillivan, Diane L Raccasi, Dianne S Alexander, Dinesh Kumar, Dino A Fiegelstock, Dmitriy V Volokhov, PhD, Douglas C Kovacs, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Eileen A Liu, Ekaterina Allen, Eliezar Ramos, Ellen Huang, Ellen P Madigan, Elmina E Akwo, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Emmanuel Jramos Maldonado, Erika V Butler, Erin D Mccaffery, Erin L Mcfiren, Frank Wackes, Freyja V Lynn, Gene D Arcy, Gianine E Tompkins, Ginger M Sykes, Guerlain Ulysse, Gunther Boekhoudt, PhD, Haitao Li, Haoheng Yan, PhD, Helen B Ricalde, Helen Verdel, Howard Anderson, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James C Lee, PharmD, James C Maclaughlin, James E Keller, PhD, James M Mason, James R Evans, Jawaid Hamid, Jee Chung, PhD, Jeffrey D Meng, Jeffrey M Watson, Jennifer L Bridgewater, Jennifer L Reed, Jennifer L Schmidt, Jennifer Swisher, PhD, Joan A Loreng, Joan Johnson, Jogy George, John F Cipollo, John M Mcinnis, Jonathan W Chapman, Jose Acruz Gonzalez, Jose M Cayuela, Joseph George, Joshua J Silvestri, Joy Rkozlowski Klena, Joyce A Rockwell, Julie D Bringger, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Karen E D'orazio, Karen L Kosar, Kathleen R Jones, PhD, Kevin A Gonzalez, Kevin P Foley, Kimberley A Hoefen, Kirsten L Vadheim, PhD, Kristina L Conroy, Kristy A Zielny, Larry K Austin, Lata C Mathew, PhD, Laurel A Beer, Laurie P Norwood, LCDR Debra Emerson, Leslie D Wagner, Li Lu, PhD, Linda R Kuchenthal, Linda Thai, Lisa M Parsons, Lloyd D Payne, Lori Peters, Malgorzata G Norton, PhD, Maotang Zhou, PhD, Margaret M Annes, Maria Joselopez Barragan, PhD, Marion Michaelis, Mariza M Jafary, Marjorie A Shapiro, PhD, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew A Spataro, Maxwell Van Tassell, PhD, Megan A Haggerty, Melissa T Roy, Michael A Charles, Michael R Klapal, Michele L Forster, PhD, Michelle M Noe Varga, Mihaly S Ligmond, Milan S Blake, Minh D Phan, Monique C Lo, Nailing Zhang, Nancy E Kirschbaum, Nancy F Scheraga, Nancy T Waites, Nebil A Oumer, Nicole K Trudel, Niketa Patel, Nikisha M Bolden, Nobuko H Katagiri, Ogechi C Nna, Omotunde O Osunsanmi, Pankaj H Amin, Patsy J Domingo, Paul J Teitell, Paul L Bellamy, Paul Lihong Yeh, PhD, Paul Mouris, Paul Z Balcer, Paula A Trost, Perry T Nichols, Prabhu P Raju, Priscilla M Pastrana, Qin Xu, Ralph A Erickson, Randa Melhem, PhD, Rebecca E Dombrowski, Rebecca K Olin, Regina T Brown, Reginald Walker, Richard H Penta, Robert D Tollefsen, Robert J Martin, Robert Jennings, Robert Sausville, Robin Levis, PhD, Robin P Mathew, Roman T Drews, PhD, Rose Ashley, Sanket N Patel, Sarah B Tanksley, Sarah M Napier, Scott E Norris, Sean R Marcsisin, Sena G Dissmeyer, Seth A Mailhot, Shererk, Sidney B Priesmeyer, Simone E Pitts, Solomon Yimam (SY), Stacey S Degarmo, Stephanie A Slater, MS, Stephen D Brown, Steven C Madzo, Steven Kozlowski, MD, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Tamil Arasu, PhD, Teresa Jimenez, Terri L Dodds, Thai D Truong, Thomas J Arista, Tina S Roecklein, Toyin B Oladimeji, Tracy J Washington, Unnee Ranjan, Verlinda A Narcisse, Veronica L Call, Victor J Gangi, Vijaya L Simhadri, Viviana Matta, Walter N Lange, Wanda J Torres, Wayne E Seifert, Wei Wang, PhD, Xu Michael Di, PhD, Yanming An, PhD, Yasamin Ameri, Yvins Dezan, Zachary L Miller, Zachary L Stamm, Zakaria I Ganiyu, Zhao Wang, PhD, Zhijin Chen, Zhong Li, PhD, Zuben E Sauna, PhD

Richard W Thornton's Documents

Publish Date Document Type Title
August, 2000 FDA 483 Response DPT Lakewood, Inc. - Form 483R, 2000-09-01
January, 2000 FDA 483 Enzon Pharmaceuticals, Inc - Form 483, 2000-01-20
December, 2000 EIR Bayer HealthCare LLC - EIR, 2000-12-07
January, 2002 FDA 483 Response Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483R, 2002-02-25
January, 2002 EIR Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2002-01-24
March, 2002 FDA 483 DPT Lakewood, Inc. - Form 483, 2002-03-21
March, 2002 FDA 483 Response Halo Pharmaceuticals Inc. - Form 483R, 2002-03-27
July, 2001 FDA 483 Medimmune Inc. - Form 483, 2001-07-19
December, 2001 FDA 483 Amgen Inc. - Form 483, 2001-12-06
September, 2000 FDA 483 Response Aventis Behring Gmbh - Form 483R, 2000-10-13
March, 2002 EIR Halo Pharmaceuticals Inc. - EIR, 2002-03-06
June, 2000 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2000-06-13
January, 2002 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2002-01-24
September, 2000 FDA 483 GSK Vaccines GmbH - Form 483, 2000-09-01
April, 2001 EIR GlaxoSmithKline - EIR, 2001-04-30
March, 2002 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2002-03-06
July, 2001 EIR AstraZeneca Pharmaceuticals LP - EIR, 2001-07-19
December, 2000 FDA 483 Bayer HealthCare LLC - Form 483, 2000-12-07
August, 2000 FDA 483 DPT Lakewood, Inc. - Form 483, 2000-08-11
September, 2000 EIR Aventis Behring Gmbh - EIR, 2000-11-03
September, 2000 FDA 483 Aventis Behring Gmbh - Form 483, 2000-09-13
October, 2001 FDA 483 OKC Allergy Supplies, Inc. - Form 483, 2001-10-24
April, 2001 FDA 483 GlaxoSmithKline - Form 483, 2001-04-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more